Sterneck Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Sterneck Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Sell	3,170 -30	-0.9%	-$16.3K	0.7%	28
2025 Q4	$1.85M	Hold	3,200	–	–	0.84%	28
2025 Q3	$1.55M	Hold	3,200	–	–	0.72%	30
2025 Q2	$1.3M	Hold	3,200	–	–	0.66%	31
2025 Q1	$1.59M	Hold	3,200	–	–	0.86%	29
2024 Q4	$1.66M	Hold	3,200	–	–	0.9%	28
2024 Q3	$1.98M	Hold	3,200	–	–	1.07%	25
2024 Q2	$1.77M	Hold	3,200	–	–	1%	28
2024 Q1	$1.86M	Hold	3,200	–	–	1.11%	28
2023 Q4	$1.7M	Sell	3,200 -2	-0.1%	-$968	1.08%	27
2023 Q3	$1.62M	Hold	3,202	–	–	1.08%	26
2023 Q2	$1.67M	Hold	3,202	–	–	1.02%	27
2023 Q1	$1.85M	Buy	3,202 +2	+0.1%	+$1.13K	1.16%	27
2022 Q4	$1.76M	Hold	3,200	–	–	1.17%	26
2022 Q3	$1.62M	Hold	3,200	–	–	1.15%	28
2022 Q2	$1.74M	Hold	3,200	–	–	1.16%	29
2022 Q1	$1.89M	Hold	3,200	–	–	1.13%	27
2021 Q4	$2.13M	Hold	3,200	–	–	1.26%	24
2021 Q3	$1.83M	Hold	3,200	–	–	1.16%	28
2021 Q2	$1.69M	Hold	3,200	–	–	1.05%	30
2021 Q1	$1.46M	Hold	3,200	–	–	1.02%	30
2020 Q4	$1.49M	Hold	3,200	–	–	1.12%	26
2020 Q3	$1.41M	Hold	3,200	–	–	1.19%	24
2020 Q2	$1.16M	Hold	3,200	–	–	1.09%	25
2020 Q1	$908K	Hold	3,200	–	–	0.91%	30
2019 Q4	$1.04M	Hold	3,200	–	–	0.83%	36
2019 Q3	$932K	Hold	3,200	–	–	0.85%	32
2019 Q2	$940K	Hold	3,200	–	–	0.81%	33
2019 Q1	$876K	Hold	3,200	–	–	0.77%	33
2018 Q4	$716K	Hold	3,200	–	–	0.7%	38
2018 Q3	$781K	Sell	3,200 -350	-10%	-$80.5K	0.56%	45
2018 Q2	$735K	Hold	3,550	–	–	0.51%	49
2018 Q1	$733K	Hold	3,550	–	–	0.43%	63
2017 Q4	$674K	Hold	3,550	–	–	0.4%	63
2017 Q3	$672K	Sell	3,550 -100	-3%	-$18.1K	0.39%	70
2017 Q2	$637K	Hold	3,650	–	–	0.38%	69
2017 Q1	$561K	Buy	3,650 +450	+14%	+$68.8K	0.33%	77
2016 Q4	$452K	Hold	3,200	–	–	0.29%	82
2016 Q3	$509K	Buy	3,200 +75	+2%	+$11.6K	0.34%	78
2016 Q2	$462K	Hold	3,125	–	–	0.31%	83
2016 Q1	$442K	Hold	3,125	–	–	0.31%	77
2015 Q4	$443K	Hold	3,125	–	–	0.28%	79
2015 Q3	$382K	Hold	3,125	–	–	0.25%	84
2015 Q2	$406K	Hold	3,125	–	–	0.22%	89
2015 Q1	$420K	Sell	3,125 -150	-5%	-$19.3K	0.23%	89
2014 Q4	$410K	Hold	3,275	–	–	0.24%	79
2014 Q3	$399K	Hold	3,275	–	–	0.24%	82
2014 Q2	$386K	Hold	3,275	–	–	0.23%	84
2014 Q1	$394K	Hold	3,275	–	–	0.21%	86
2013 Q4	$365K	Hold	3,275	–	–	0.22%	96
2013 Q3	$302K	Sell	3,275 -100	-3%	-$9.04K	0.19%	118
2013 Q2	$286K	Buy	+3,375	New	+$281K	0.18%	117

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sterneck Capital Management's TMO Position: Q1 2026 in Review

Sterneck Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.94% in Q1 2026, selling an estimated $16.3K and leaving 3,170 shares worth $1.56M. The position accounts for 0.7% of the portfolio, ranked #28.

Sterneck Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.13M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Sterneck Capital Management held 3,170 shares of Thermo Fisher Scientific worth $1.56M as of Q1 2026.
Sterneck Capital Management sold 30 Thermo Fisher Scientific shares in Q1 2026, an estimated $16.3K.
Thermo Fisher Scientific made up 0.7% of Sterneck Capital Management's portfolio in Q1 2026, its #28 holding.
Sterneck Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
Sterneck Capital Management's Thermo Fisher Scientific position peaked at $2.13M in Q4 2021.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sterneck Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.